Cargando…

Cefiderocol against Multi-Drug and Extensively Drug-Resistant Escherichia coli: An In Vitro Study in Poland

Cefiderocol (CFDC) is a novel, broad-spectrum siderophore cephalosporin with potential activity against multi-drug (MDR) and extensively drug-resistant (XDR) Enterobacterales, including carbapenem-resistant strains. We assessed the in vitro susceptibility to CFDC of MDR, and XDR E. coli isolates der...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zalas-Więcek, Patrycja, Płachta, Katarzyna, Gospodarek-Komkowska, Eugenia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785875/ https://www.ncbi.nlm.nih.gov/pubmed/36558842 http://dx.doi.org/10.3390/pathogens11121508

Ejemplares similares

The Accelerate Pheno™ System—A New Tool in Microbiological Diagnostics of Bloodstream Infections: A Pilot Study from Poland
por: Zalas-Więcek, Patrycja, et al.
Publicado: (2022)

Candida auris Infection in a Meningococcal Septicemia Survivor, Poland
por: Prażyńska, Małgorzata, et al.
Publicado: (2022)

Virulence-associated genes and antibiotic susceptibility among vaginal and rectal Escherichia coli isolates from healthy pregnant women in Poland
por: Kaczmarek, Agnieszka, et al.
Publicado: (2018)

Virulence genes and antimicrobial susceptibility of lactose-negative and lactose-positive strains of Escherichia coli isolated from pregnant women and neonates
por: Kaczmarek, Agnieszka, et al.
Publicado: (2017)

In Vitro Activity of Cefiderocol against Extensively Drug-Resistant Pseudomonas aeruginosa: CANWARD, 2007 to 2019
por: Karlowsky, James A., et al.
Publicado: (2022)

Proteomic Investigation of the Antibacterial Mechanism of Cefiderocol against Escherichia coli
por: Du, Gao-Fei, et al.
Publicado: (2022)

In Vitro Activity of Cefiderocol against Multi-Drug Resistant Carbapenemase-Producing Gram-Negative Pathogens
por: Boyd, Sandra, et al.
Publicado: (2017)

Comparison of the intensity of biofilm formation by Listeria monocytogenes using classical culture-based method and digital droplet PCR
por: Grudlewska-Buda, Katarzyna, et al.
Publicado: (2020)

Cefiderocol is an effective topical monotherapy for experimental extensively-drug resistant Pseudomonas aeruginosa keratitis
por: Romanowski, Eric G., et al.
Publicado: (2023)

Antibiotic Resistance of Enterococcus spp. Isolated from the Urine of Patients Hospitalized in the University Hospital in North-Central Poland, 2016–2021
por: Kraszewska, Zuzanna, et al.
Publicado: (2022)

Case Report: Successful Rescue Therapy of Extensively Drug-Resistant Acinetobacter baumannii Osteomyelitis With Cefiderocol
por: Dagher, Michael, et al.
Publicado: (2020)

Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France
por: Jousset, Agnès B., et al.
Publicado: (2023)

Feasibility of Continuous Infusion of Cefiderocol in Conjunction with the Establishment of Therapeutic Drug Monitoring in Patients with Extensively Drug-Resistant Gram-Negative Bacteria
por: Prinz, Carolin, et al.
Publicado: (2023)

Detection of K1 antigen of Escherichia coli rods isolated from pregnant women and neonates
por: Kaczmarek, Agnieszka, et al.
Publicado: (2014)

Evaluation of eazyplex(®) SuperBug CRE Test for Beta-Lactamase Genes Detection in Klebsiella spp. and P. aeruginosa Strains
por: Sękowska, Alicja, et al.
Publicado: (2019)

An Application of Imipenem Discs or P. aeruginosa ATCC 27853 Reference Strain Increases Sensitivity of Carbapenem Inactivation Method for Non-Fermenting Gram-Negative Bacteria
por: Bogiel, Tomasz, et al.
Publicado: (2021)

Multi-label classification for multi-drug resistance prediction of Escherichia coli
por: Ren, Yunxiao, et al.
Publicado: (2022)

Assessment of the Prevalence and Drug Susceptibility of Listeria monocytogenes Strains Isolated from Various Types of Meat
por: Skowron, Krzysztof, et al.
Publicado: (2020)

Multidrug-Resistant and Extensively Drug-Resistant Escherichia coli in Sewage in Kuwait: Their Implications
por: Redha, Mahdi A., et al.
Publicado: (2023)

Chelation in Antibacterial Drugs: From Nitroxoline to Cefiderocol and Beyond
por: Repac Antić, Davorka, et al.
Publicado: (2022)

Primary and Secondary Bacteremia Caused by Proteus spp.: Epidemiology, Strains Susceptibility and Biofilm Formation
por: KWIECIŃSKA-PIRÓG, JOANNA, et al.
Publicado: (2018)

Cefiderocol for treatment of an empyema due to extensively drug-resistant Pseudomonas aeruginosa: Clinical observations and susceptibility testing considerations
por: Kufel, Wesley D., et al.
Publicado: (2020)

Complete Genome Sequence of Escherichia Phage 590B, Active against an Extensively Drug-Resistant Uropathogenic Escherichia coli Isolate
por: Chaudhary, Naveen, et al.
Publicado: (2021)

Ceftazidime/Avibactam and Other Commonly Used Antibiotics Activity Against Enterobacterales and Pseudomonas aeruginosa Isolated in Poland in 2015–2019
por: Zalas-Więcek, Patrycja, et al.
Publicado: (2022)

Pharmacokinetic Analysis and In Vitro Synergy Evaluation of Cefiderocol, Sulbactam, and Tigecycline in an Extensively Drug-Resistant Acinetobacter baumannii Pneumonia Patient Receiving Continuous Venovenous Hemodiafiltration
por: Kobic, Emir, et al.
Publicado: (2022)

Role of wild birds as carriers of multi-drug resistant Escherichia coli and Escherichia vulneris
por: Shobrak, Mohammed Y., et al.
Publicado: (2015)

Diagnostic Value of Whole-Blood and Plasma Samples in Epstein–Barr Virus Infections
por: Rzepka, Mateusz, et al.
Publicado: (2023)

Whole Blood versus Plasma Samples—How Does the Type of Specimen Collected for Testing Affect the Monitoring of Cytomegalovirus Viremia?
por: Rzepka, Mateusz, et al.
Publicado: (2022)

The Prevalence of Virulence Factor Genes among Carbapenem-Non-Susceptible Acinetobacter baumannii Clinical Strains and Their Usefulness as Potential Molecular Biomarkers of Infection
por: Depka, Dagmara, et al.
Publicado: (2023)

Compassionate Use of Cefiderocol to Treat a Case of Prosthetic Joint Infection Due to Extensively Drug-Resistant Enterobacter hormaechei
por: Siméon, Soline, et al.
Publicado: (2020)

High genomic diversity of multi-drug resistant wastewater Escherichia coli
por: Mahfouz, Norhan, et al.
Publicado: (2018)

2118. Comparative Analysis of Cefiderocol Mono- and Combination Therapy for Multi-Drug Resistant Gram-negative Infections
por: Ghali, Amer El, et al.
Publicado: (2023)

The Ciprofloxacin Impact on Biofilm Formation by Proteus Mirabilis and P. Vulgaris Strains
por: Kwiecinska-Pirog, Joanna, et al.
Publicado: (2016)

Influence of Selected Factors on Biofilm Formation by Salmonella enterica Strains
por: Białucha, Agata, et al.
Publicado: (2020)

In Vitro Activity of Cefiderocol on Multiresistant Bacterial Strains and Genomic Analysis of Two Cefiderocol Resistant Strains
por: Padovani, Michela, et al.
Publicado: (2023)

Cefiderocol
por: Soriano, María Cruz, et al.
Publicado: (2022)

In Vitro Activity and In Vivo Efficacy of Cefiderocol against Stenotrophomonas maltophilia
por: Nakamura, Rio, et al.
Publicado: (2021)

Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance
por: König, Christina, et al.
Publicado: (2021)

Detection of multi-drug resistant Escherichia coli in the urban waterways of Milwaukee, WI
por: Kappell, Anthony D., et al.
Publicado: (2015)

Multi-drug and β-lactam resistance in Escherichia coli and food-borne pathogens
por: Costa, M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4pe90d668qat6l9o0p5d1paqo7